Skip to main content
All lobbying clients

VIATRIS INC

Lobbying client · Pennsylvania · filed 2025 to 2026

$4,600,000 Reported spend
24 Filings counted
3 Outside firms hired
16 Bills named

Spend is reported income plus in-house expenses across 24 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 4 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as VIATRIS INC.

 Who filed for this client 4

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 16
  • S. 1302
    Increasing Transparency in Generic Drug Applications Act
    11 filings
  • S. 891
    Bipartisan Health Care Act
    7 filings
  • H.R. 4132
    Prescription Information Modernization Act of 2025
    6 filings
  • S. 2027
    Prescription Information Modernization Act of 2025
    6 filings
  • S. 2296
    National Defense Authorization Act for Fiscal Year 2026
    6 filings
  • H.R. 1843
    To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
    5 filings
  • S. 2658
    Medication Affordability and Patent Integrity Act
    5 filings
  • H.R. 9747
    Continuing Appropriations and Extensions Act, 2025
    4 filings
  • S. 1071
    National Defense Authorization Act for Fiscal Year 2026
    4 filings
  • S. 3778
    Carbon Resource Innovation Act
    3 filings
  • S. 3841
    Last Sale Valuation Act of 2026
    3 filings
  • H.R. 1503
    Prescription Information Modernization Act of 2023
    1 filing
  • H.R. 5461
    Ensuring Access to Lower-Cost Medicines for Seniors Act of 2023
    1 filing
  • S. 2129
    Ensuring Access to Lower-Cost Medicines for Seniors Act
    1 filing
  • S. 2916
    Prescription Information Modernization Act of 2023
    1 filing
  • S. 775
    Increasing Transparency in Generic Drug Applications Act
    1 filing
 Reported by year 2 years
  • 2026 $1,660,000 9 filings
  • 2025 $2,940,000 15 filings
 Issues lobbied 8

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 9
  • HOUSE OF REPRESENTATIVES 24
  • SENATE 24
  • Centers For Medicare and Medicaid Services (CMS) 14
  • Commerce, Dept of (DOC) 12
  • Health & Human Services, Dept of (HHS) 7
  • Executive Office of the President (EOP) 6
  • Natl Economic Council (NEC) 6
  • U.S. Trade Representative (USTR) 6
  • Securities & Exchange Commission (SEC) 3
 Recent filings 24 total
Q3 report
VIATRIS INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $450,000 expenses · posted Oct 20, 2026
View →
Q3 report
FEROX STRATEGIES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $70,000 income · posted Oct 19, 2026
View →
Q3 report
HOLLAND & KNIGHT LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 7, 2026
View →
Q2 report
VIATRIS INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $360,000 expenses · posted Jul 20, 2026
View →
Q2 report
FEROX STRATEGIES
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 20, 2026
View →
Q2 report
HOLLAND & KNIGHT LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 13, 2026
View →
Q1 report
VIATRIS INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $490,000 expenses · posted Apr 20, 2026
View →
Q1 report
FEROX STRATEGIES
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $70,000 income · posted Apr 17, 2026
View →
Q1 report
HOLLAND & KNIGHT LLP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 4, 2026
View →
Q4 report
VIATRIS INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $490,000 expenses · posted Jan 20, 2026
View →
Q4 report
FEROX STRATEGIES
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $70,000 income · posted Jan 20, 2026
View →
Q4 report
HOLLAND & KNIGHT LLP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 18, 2026
View →
Q3 termination
BLUE RIDGE LAW & POLICY, P.C.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2025
View →
Q3 report
VIATRIS INC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $640,000 expenses · posted Oct 20, 2025
View →
Q3 report
HOLLAND & KNIGHT LLP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 18, 2025
View →
Q3 report
FEROX STRATEGIES
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $70,000 income · posted Oct 13, 2025
View →
Q2 report
BLUE RIDGE LAW & POLICY, P.C.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 22, 2025
View →
Q2 report
VIATRIS INC.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $590,000 expenses · posted Jul 21, 2025
View →
Q2 report
FEROX STRATEGIES
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 18, 2025
View →
Q2 report
HOLLAND & KNIGHT LLP
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 17, 2025
View →

Showing the 20 most recent of 24 filings. Search the explorer for "VIATRIS INC".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem